MILLENNIUM MANAGEMENT LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 73 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$704,000
-65.1%
146,750
-54.9%
0.00%
-66.7%
Q2 2019$2,018,000
-72.1%
325,417
-68.0%
0.00%
-72.7%
Q1 2019$7,238,000
+76.6%
1,017,983
+112.1%
0.01%
+83.3%
Q4 2018$4,098,000
-18.3%
479,899
+91.6%
0.01%0.0%
Q3 2018$5,015,000
-43.3%
250,495
-26.8%
0.01%
-50.0%
Q2 2018$8,839,000
+352.1%
342,180
+318.2%
0.01%
+300.0%
Q1 2018$1,955,000
-91.2%
81,820
-87.5%
0.00%
-90.3%
Q4 2017$22,269,000
-16.6%
657,083
-47.9%
0.03%
-24.4%
Q3 2017$26,686,000
+352.2%
1,260,579
+273.6%
0.04%
+272.7%
Q2 2017$5,901,000
-23.9%
337,376
-23.9%
0.01%
-21.4%
Q1 2017$7,754,000
-15.0%
443,067
-17.9%
0.01%
-26.3%
Q4 2016$9,123,000
-22.5%
539,849
-24.7%
0.02%
-5.0%
Q3 2016$11,772,000
+39.7%
717,375
+28.9%
0.02%
+5.3%
Q2 2016$8,426,000
+4071.3%
556,569
+3877.8%
0.02%
+1800.0%
Q1 2016$202,000
-98.1%
13,992
-96.3%
0.00%
-95.5%
Q4 2015$10,570,000
+1079.7%
373,240
+597.0%
0.02%
+1000.0%
Q3 2015$896,000
+93.5%
53,551
+203.1%
0.00%
+100.0%
Q2 2015$463,000
-40.9%
17,668
-60.5%
0.00%0.0%
Q1 2015$783,000
+267.6%
44,755
+265.2%
0.00%
Q4 2014$213,00012,2550.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 808,431$3,501,0002.68%
AIGH Capital Management LLC 875,851$3,793,0001.54%
Healthcare Value Capital, LLC 100,000$433,0001.46%
SILVERARC CAPITAL MANAGEMENT, LLC 440,955$1,909,0001.11%
Opaleye Management Inc. 1,487,800$6,442,0000.84%
Worth Venture Partners, LLC 225,106$975,0000.77%
ARMISTICE CAPITAL, LLC 2,742,000$11,873,0000.40%
DELTEC ASSET MANAGEMENT LLC 245,399$1,063,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 278,011$1,204,0000.15%
Mosaic Family Wealth, LLC 91,807$398,0000.13%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders